Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05651230 · ClinicalTrials.gov registry record · NA
Seaweed-derived Rhamnan Sulfate and Vascular Function
A NA study, sponsored by University of Texas at Austin.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT05651230 is a NA study that has completed, run by University of Texas at Austin. The registered enrollment target is 15 participants.
The verdict
NCT05651230, a NA study, has completed, sponsored by University of Texas at Austin.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
The primary aim of the proposed investigation is to examine the hypothesis that a relatively short period of rhamnan sulfate supplementation would improve key markers of vascular dysfunction in middle-aged and older adults with at least one risk factors for cardiovascular disease.
Interventions
- DIETARY_SUPPLEMENT Rhamnan sulfate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2023-04-01 |
| Est. Completion | 2025-02-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05651230
The ClinicalTrials.gov registry entry for NCT05651230 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas at Austin, which has 257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Rhamnan sulfate is the first listed.
NCT05651230 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05651230 about?
NCT05651230 is a clinical study titled "Seaweed-derived Rhamnan Sulfate and Vascular Function". The primary aim of the proposed investigation is to examine the hypothesis that a relatively short period of rhamnan sulfate supplementation would improve key markers of vascular dysfunction in middle-aged and older adults with at least one risk factors for cardiovascular disease.
What is the current status of trial NCT05651230?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2023-04-01. Estimated completion is 2025-02-01.
What interventions are being tested in trial NCT05651230?
The interventions under investigation include: Rhamnan sulfate (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05651230?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.